Ivermectina para COVID-19 (18 feb. 2021)

Instituto de Efectividad Clínica y Sanitaria.

Publication year: 2021

Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Betacoronavirus/drug effects, Ivermectin/therapeutic use, Technology Assessment, Biomedical, Health Evaluation, Cost-Benefit Analysis

Fulltext

More related

WordPress version 6.1.1
BVS-Site Plugin version 0.3